DK1227843T3 - Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter - Google Patents

Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter

Info

Publication number
DK1227843T3
DK1227843T3 DK00992499.4T DK00992499T DK1227843T3 DK 1227843 T3 DK1227843 T3 DK 1227843T3 DK 00992499 T DK00992499 T DK 00992499T DK 1227843 T3 DK1227843 T3 DK 1227843T3
Authority
DK
Denmark
Prior art keywords
patients
cytokine inhibitor
removing cytokine
binds
molecule
Prior art date
Application number
DK00992499.4T
Other languages
English (en)
Inventor
M Rigdon Lentz
Original Assignee
Biopheresis Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopheresis Technologies Inc filed Critical Biopheresis Technologies Inc
Application granted granted Critical
Publication of DK1227843T3 publication Critical patent/DK1227843T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
DK00992499.4T 1999-11-10 2000-11-10 Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter DK1227843T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16469599P 1999-11-10 1999-11-10
PCT/US2000/042090 WO2001037873A2 (en) 1999-11-10 2000-11-10 Method and system to remove cytokine inhibitor in patients

Publications (1)

Publication Number Publication Date
DK1227843T3 true DK1227843T3 (da) 2010-02-15

Family

ID=22595665

Family Applications (2)

Application Number Title Priority Date Filing Date
DK09005155.8T DK2087907T3 (da) 1999-11-10 2000-11-10 Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter
DK00992499.4T DK1227843T3 (da) 1999-11-10 2000-11-10 Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK09005155.8T DK2087907T3 (da) 1999-11-10 2000-11-10 Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter

Country Status (10)

Country Link
EP (2) EP1227843B1 (da)
JP (2) JP3852755B2 (da)
AT (1) ATE445414T1 (da)
AU (1) AU783238B2 (da)
CA (1) CA2390095C (da)
DE (1) DE60043156D1 (da)
DK (2) DK2087907T3 (da)
ES (2) ES2528307T3 (da)
PT (1) PT2087907E (da)
WO (1) WO2001037873A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014983A1 (de) 2004-03-26 2005-10-20 Univ Stuttgart Rekombinante Polypeptide der Mitglieder der TNF Ligandenfamilie und deren Verwendung
AU2005240082B2 (en) * 2004-04-30 2009-07-23 Innatus Corporation Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients
UY30915A1 (es) * 2007-02-16 2008-09-02 Smithkline Beecham Corp Método de tratamiento de canceres
WO2012163544A1 (en) 2011-06-01 2012-12-06 Biopheresis Technologies, Inc. Removal of soluble tumor necrosis factor receptor 2 (stnfr2)
WO2013179143A2 (en) 2012-06-01 2013-12-05 Biopheresis Technologies, Inc. Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors
EA035898B1 (ru) 2014-10-03 2020-08-28 НАНОТИКС, ЭлЭлСи Композиции и способы для ингибирования биологической активности растворимых биомолекул
CN104353061B (zh) * 2014-11-17 2017-05-17 沈阳三生制药有限责任公司 血小板生成素在辐射造成肠组织损伤中的应用
KR20180034619A (ko) 2015-07-29 2018-04-04 나노틱스 엘엘씨 가용성 생체분자를 소거하기 위한 모듈 조성물 및 이와 관련된 방법
EP3374399A1 (en) 2015-11-11 2018-09-19 Opi Vi- IP Holdco LLC Composition and methods for anti-tnfr2 antibodies
WO2018129207A1 (en) 2017-01-04 2018-07-12 Nanotics, Llc Methods for assembling scavenging particles
WO2019053031A1 (en) 2017-09-13 2019-03-21 Bavarian Immunology Association GmbH PURIFIED BLOOD FOR USE IN ANTICANCER THERAPY

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708713A (en) 1984-11-16 1987-11-24 Anisa Medical, Inc. Method and system for removing immunosuppressive components from the blood of mammals
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
JPH07106219B2 (ja) * 1988-08-02 1995-11-15 宇部興産株式会社 インターロイキン２レセプターの除去装置およびそれを備えた血液体外循環装置
ATE150750T1 (de) 1988-09-01 1997-04-15 Takeda Chemical Industries Ltd Fumagillol-derivate
US5147638A (en) 1988-12-30 1992-09-15 Oklahoma Medical Research Foundation Inhibition of tumor growth by blockade of the protein C system
US5290807A (en) 1989-08-10 1994-03-01 Children's Medical Center Corporation Method for regressing angiogenesis using o-substituted fumagillol derivatives
CA2149881A1 (en) * 1992-11-19 1994-05-26 Paul T. Jubinsky Antibodies for gm-csf receptor and uses thereof
US5629327A (en) 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
CN1137257A (zh) 1993-11-12 1996-12-04 Idv经营爱尔兰公司 倾倒至少两种不同液体的倾倒器
US5639725A (en) 1994-04-26 1997-06-17 Children's Hospital Medical Center Corp. Angiostatin protein
JP4170421B2 (ja) * 1996-08-06 2008-10-22 佳子 安田 増殖性臓器疾患治療・改善剤
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers

Also Published As

Publication number Publication date
ES2528307T3 (es) 2015-02-06
PT2087907E (pt) 2015-01-05
EP1227843B1 (en) 2009-10-14
AU783238B2 (en) 2005-10-06
ATE445414T1 (de) 2009-10-15
JP2006249112A (ja) 2006-09-21
EP1227843A2 (en) 2002-08-07
ES2356369T3 (es) 2011-04-07
EP2087907A3 (en) 2009-08-19
DE60043156D1 (de) 2009-11-26
JP2003514622A (ja) 2003-04-22
AU4505601A (en) 2001-06-04
JP3852755B2 (ja) 2006-12-06
CA2390095C (en) 2013-01-08
CA2390095A1 (en) 2001-05-31
WO2001037873A2 (en) 2001-05-31
EP2087907B1 (en) 2014-09-24
WO2001037873A3 (en) 2002-03-07
DK2087907T3 (da) 2015-01-12
EP2087907A2 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
DK2103960T3 (da) Metode og anordning til bestemmelse af en position i et rør
FR2757209B1 (fr) Dispositif et procede d'obturation pour tubages de puits
NO20023716D0 (no) Anordning og fremgangsmåte for et alternativt banesystem
NO20015179D0 (no) Anordning og fremgangsmåte for venturispyling
DE69802263D1 (de) Einrichtung und verfahren zum ausrichten von rohren
DK1196974T3 (da) Fremgangsmåde og apparat til opdeling af en ledningskanal i sektioner
DE59703595D1 (de) Vorrichtung zum Halten von Rohren
NO20025415L (no) Anordning og fremgangsmåte for automatisk tilbakeslagsregulering i stigerör
DK1227843T3 (da) Fremgangsmåde og system til fjernelse af cytokininhibitor i patienter
NO20000188D0 (no) Fremgangsmåte og anordning for sidebroenntilknytning
NO993025L (no) Fremgangsmåte og innretning for rensing av skinnespor
IT238524Y1 (it) Dispositivo fissatubi perfezionato
FR2790621B1 (fr) Dispositif et procede d'entrelacement pour turbocodage et turbodecodage
NO964622L (no) Festeklemme for jernbaneskinne og anordning
FR2787366B1 (fr) Procede et dispositif d'enlevement d'une plaque retenue par adhesif a une piece support
DK0759879T3 (da) Fremgangsmåde og indretning til overføring af moduler
FR2798615B1 (fr) Dispositif et procede pour produire des panneaux de parquet
DK0993611T3 (da) Fremgangsmåde og anordning til detektion af blod i æg
ID24055A (id) Peralatan untuk pengikatan amorfus pada pipa-pipa
NO20015089D0 (no) System og fremgangsmåte for konvertert-bölge-analyse
DK1041237T3 (da) Fremgangsmåde og indretning til automatisk böjningsindstilling
FI20011418A (fi) Menetelmä ja laite signaalin vastaanottamiseksi optisessa CDMA-järjestelmässä
NO993040L (no) Fremgangsmåte og anordning for injisering
NO964597D0 (no) Anordning for bruk i forbindelse med brönn-forlengelsesrör
FR2771500B1 (fr) Procede et dispositif d'aide au creneau